MELT PHARMACEUTICALS Trademark

Trademark Overview


On Friday, September 30, 2022, a trademark application was filed for MELT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the MELT PHARMACEUTICALS trademark a serial number of 97979229. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, December 11, 2024. This trademark is owned by Melt Pharmaceuticals, Inc.. The MELT PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of medications; Research and development of medications for preoperative use; Research and development of pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation
melt pharmaceuticals

General Information


Serial Number97979229
Word MarkMELT PHARMACEUTICALS
Filing DateFriday, September 30, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, December 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesResearch and development of medications; Research and development of medications for preoperative use; Research and development of pharmaceutical compositions for administration prior to, during, or after a surgical procedure for conscious sedation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2022
Primary Code042
First Use Anywhere DateThursday, August 13, 2020
First Use In Commerce DateThursday, August 13, 2020

Trademark Owner History


Party NameMelt Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37205

Party NameMelt Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37205

Trademark Events


Event DateEvent Description
Tuesday, October 4, 2022NEW APPLICATION ENTERED
Tuesday, October 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, May 25, 2023ASSIGNED TO EXAMINER
Friday, May 26, 2023NON-FINAL ACTION WRITTEN
Friday, May 26, 2023NON-FINAL ACTION E-MAILED
Friday, May 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 12, 2024SOU EXTENSION 1 FILED
Monday, February 12, 2024SOU EXTENSION 1 GRANTED
Monday, February 12, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024USE AMENDMENT FILED
Wednesday, September 11, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, September 11, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, September 11, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, November 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 20, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 20, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, December 11, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 11, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED